LV-GB Complex TM
LV-GB Complex TM, licence 80051371: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Designs for Health
- NPN or DIN-HM
- 80051371
- Status
- Active licence
- Licence date
- 3 June 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 5.1 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B6 | 1.7 mg | 5,100 µg |
| Vitamine B12 | 5.0 microgrammes | Not calculated |
| Silybum marianum Source : New material Potency : 80.0 % Silymarin | Not specified | Not calculated |
| Silybum marianum Source : New material | 33.3 mg | Not calculated |
| Silybum marianum Source : Graine(s) Potency : 80.0 % silymarin | 33.3 mg | Not calculated |
| bêta-carotène | 1000.0 mcg | Not calculated |
| bêta-carotène | 1666.7 UI | Not calculated |
| Lécithine Source : Glycine max - Graine | 33.3 mg | Not calculated |
| Chelidonium majus Source : En entier | 16.7 mg | Not calculated |
| Bos taurus Source : Bile | 25.0 mg | Not calculated |
| Cynara cardunculus Source : Feuille | 16.7 mg | Not calculated |
| Cynara cardunculus Source : Feuille Potency : 5.0 % Cynarin | Not specified | Not calculated |
| Vitamine B12 | 5.0 mcg | 15 µg |
| Beta vulgaris Source : Tubercule | 8.3 mg | Not calculated |
Non-medicinal ingredients
farine de riz, Stéarate de magnésium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 3.0 Capsule ; maximum: 3.0 Capsule | minimum: 1.0 Jour(s) ; maximum: 1.0 Jour(s) |
Uses authorised in Canada
Helps to support liver function. Helps the body to metabolize carbohydrates, fats and proteins. Source of vitamin A to help maintain eyesight, skin, membranes and immune function. A factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family. Do not use if you have a bile duct obstruction. Do not use if you have existing or previous liver disease, or are using substances contraindicated in liver disease. Do not use if you are pregnant or breastfeeding. Do not use if you suffer from gastric reflux or if you have gastrointestinal lesions/ulcers.
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. If you have gall bladder diseases, and/or intestinal obstruction, and/or gallstones consult a health care practitioner prior to use.
- Effets indésirables connus
Hypersensitivity, such as allergy, has been known to occur; in which case, discontinue use. May cause liver disorder in some people; consult a health care practitioner immediately if you develop any of the following symptoms: nausea, vomiting, loss of appetite combined with itching, yellowing of the skin or eyes and dark urine.
Source
Official Health Canada record, licence 80051371
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Has the product changed? Photograph the packaging.